What does BELGIMED do?

BELGIMED is a training centre in Boechout. Private Limited, started on 1 December 1966, 1 establishment.

What is the address of BELGIMED?

The registered office of BELGIMED is located at Zagerijstraat 8, 2530 Boechout.

Is BELGIMED still active?

Yes. According to the CBE (29 October 2026) BELGIMED is active, legal situation “Normale toestand”, started on 1 December 1966.

Is BELGIMED registered on Peppol?

Yes, BELGIMED is registered on the Peppol network with ID 0208:0403810703.

What is the enterprise number of BELGIMED?

The enterprise number of BELGIMED is BE0403810703.

When was BELGIMED founded?

BELGIMED was founded on 1 December 1966.

Who are the directors of BELGIMED?

According to the 2025 annual accounts, the directors of BELGIMED are: Johannes Bogers.

Is BELGIMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 1966; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did BELGIMED make in 2025?

BELGIMED posted a profit after taxes of € 8,733 in financial year 2025.

What is the revenue of BELGIMED?

As a small company, BELGIMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 7,695.

BELGIMED (Private Limited) - Boechout - BE0403810703

Dossier BELGIMED, printed on 29 October 2026 from databakkes.be/en/0403810703/belgimed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

BELGIMED from Boechout, company number BE0403810703, closed financial year 2025 with a result of € 8,733 after tax. For that financial year BELGIMED recorded a gross margin of € 7,695 and equity of € 228,983. Compared with financial year 2024, the result moved from € -95,479 to € 8,733. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2026.

What it is worth Growing

€ 228,983

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 8,733

▲ still € 95,479 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 29,320

▼ 67% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 210,391.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 1,751

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 2,256 Gross margin 2022: € 2,256 First fiscal year in the series	€ 7,191 Gross margin 2023: € 7,191 ▲ 219% vs 2022 (€ 2,256) Favourable step	€ 6,812 Gross margin 2024: € 6,812 ▼ 5% vs 2023 (€ 7,191) Unfavourable step	€ 7,695 Gross margin 2025: € 7,695 ▲ 13% vs 2024 (€ 6,812) Favourable step	▲ 13%
Profit after taxes	€ -433 Profit after taxes 2022: € -433 First fiscal year in the series	€ 3,363 Profit after taxes 2023: € 3,363 ▲ € 3,796 vs 2022 (€ -433) Favourable step	€ -95,479 Profit after taxes 2024: € -95,479 ▼ € 98,842 vs 2023 (€ 3,363) Unfavourable step	€ 8,733 Profit after taxes 2025: € 8,733 ▲ € 104,212 vs 2024 (€ -95,479) Favourable step	▲ € 104,212
Equity	€ 312,367 Equity 2022: € 312,367 First fiscal year in the series	€ 315,730 Equity 2023: € 315,730 ▲ 1% vs 2022 (€ 312,367) Favourable step	€ 220,251 Equity 2024: € 220,251 ▼ 30% vs 2023 (€ 315,730) Unfavourable step	€ 228,983 Equity 2025: € 228,983 ▲ 4% vs 2024 (€ 220,251) Favourable step	▲ 4%
Total debts	€ 223,746 Total debts 2022: € 223,746 First fiscal year in the series	€ 249,630 Total debts 2023: € 249,630 ▲ 12% vs 2022 (€ 223,746) Unfavourable step	€ 166,203 Total debts 2024: € 166,203 ▼ 33% vs 2023 (€ 249,630) Favourable step	€ 154,481 Total debts 2025: € 154,481 ▼ 7% vs 2024 (€ 166,203) Favourable step	▼ 7%
Cash	-	€ 4,517 Cash 2023: € 4,517 First fiscal year in the series	€ 87,544 Cash 2024: € 87,544 ▲ € 83,027 vs 2023 (€ 4,517) Favourable step	€ 29,320 Cash 2025: € 29,320 ▼ 67% vs 2024 (€ 87,544) Unfavourable step	▼ 67%
Retained profit	€ 293,775 Retained profit 2022: € 293,775 First fiscal year in the series	€ 297,138 Retained profit 2023: € 297,138 ▲ 1% vs 2022 (€ 293,775) Favourable step	€ 201,659 Retained profit 2024: € 201,659 ▼ 32% vs 2023 (€ 297,138) Unfavourable step	€ 210,391 Retained profit 2025: € 210,391 ▲ 4% vs 2024 (€ 201,659) Favourable step	▲ 4%
Bank debt	€ 74,719 Bank debt 2022: € 74,719 First fiscal year in the series	€ 80,000 Bank debt 2023: € 80,000 ▲ 7% vs 2022 (€ 74,719) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 80,000) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 536,113 Balance sheet total 2022: € 536,113 First fiscal year in the series	€ 565,360 Balance sheet total 2023: € 565,360 ▲ 5% vs 2022 (€ 536,113) Unchanged	€ 386,453 Balance sheet total 2024: € 386,453 ▼ 32% vs 2023 (€ 565,360) Unchanged	€ 383,464 Balance sheet total 2025: € 383,464 ▼ 1% vs 2024 (€ 386,453) Unchanged	▼ 1%

Key figures of BELGIMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BELGIMED?

What happened at BELGIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 17, 2026 New annual accounts for financial year 2025: profit of € 8,733. filed late Source: NBB ↗
Jun 7, 2017 New establishment in Boechout. KBO
2017 Johannes Bogers became a director. NBB
Dec 1, 1966 Start of the company according to the CBE. KBO

In short

From € 433 loss in 2022 to € 8,733 profit in 2025.

Paid € 697 in corporate taxes since 2022.

Best year ever: 2025, with € 8,733 profit.

Original PDFs at the National Bank ↗

Management

DR. J.J.P.M. BOGERS 0%

The stake of DR. J.J.P.M. BOGERS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

BELGIMED

Behind BELGIMED is Johannes Bogers. The shares are held by DR. J.J.P.M. BOGERS (0%).

Directors

According to the 2025 annual accounts

Johannes Bogers

Director

Also active at: DR. J.J.P.M. BOGERS, BOMED, Ark Angels Activator Fund Beheer, Ark Angels Activator Fund

since 2017

Shareholders

DR. J.J.P.M. BOGERS

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Zagerijstraat 8

2530 Boechout

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

DR. J.J.P.M. BOGERS same network

€ 106,490 gross margin · 2025

BOMED same network

€ 39,119 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0403.810.703

VAT number

BE 0403.810.703

Registered office

Zagerijstraat 8, 2530 Boechout

Names & denominations

BELGIMED

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 December 1966

Peppol

Active · Active since 17 Sept 2025

Activities · NACE

Overige vormen van onderwijs

Activiteiten van holdings

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

BELGIMED

Warning lights

Financials

What happened to BELGIMED?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions